Celebrex Web News Log
CELEBREX
Celebrex News Log Home
Celebrex Archives
Celebrex Articles
Do I have a Celebrex Case?
Celebrex: Bar Associations
Pfizer Inc. said it found an increased risk of heart attacks and strokes for patients taking high dosages of its top-selling arthritis painkiller Celebrex, the same problem that led to the withdrawal of its one-time competitor Vioxx.
In the 2,000 patient study, 15 individuals taking 400 mgs, 20 patients taking 800 mgs and 6 patients on placebo suffered either a cardiac-related death, heart attack or stroke.
"The challenge for Pfizer now is to show why this drug should be chosen," said FitzGerald, a cardiologist at the University of Pennsylvania.
"You can't say as a result of this study that doses under 400 milligrams are absolutely safe," said Dr. Eric Matteson, a professor of medicine in the division of rheumatology at the Mayo Clinic in Rochester, Minn.
Celebrex: Lawyer: Monheit Law: Side Effects: Heart Attack: 800mg Celebrex
The company said it has no plans to remove Celebrex from the market, but the disclosure on Friday sent Pfizer's shares tumbling because of fears that it could cripple sales of what had been the most-prescribed drug for treating arthritis. Ask Monheit Law, "Do I have a Celebrex Case?"
For more information, contact:
Michael Monheit, Esquire, Monheit Law, PC
